Epithalon and cycle length: what actually matters

A woman posted in a Facebook peptide group last week: "I ran a cycle of Epithalon and Thymalin, loved it." No numbers, no cycle length, just a satisfied one-liner that a few dozen people reacted to and nobody actually answered. That is the gap I want to close here. Short answer: an Epithalon cycle runs 10 to 20 days, repeated two to three times a year, and Thymalin follows the same shape, because both come out of the same Russian bioregulator research program and both were designed to be used in pulses, not continuously.

I get versions of this question constantly, usually from people who already ran one cycle, felt something (better sleep, more energy, whatever it was), and now want to know if they should just keep going. You should not. Here is why, and what the actual evidence says about how long to run these compounds and how often to come back to them.

Why Epithalon is cycled instead of run daily

Epithalon works through two mechanisms: it appears to activate telomerase (the enzyme that rebuilds the protective caps on your chromosomes) and it restores pineal gland output of melatonin, which is the master timing signal for your circadian rhythm. Both mechanisms are compensatory. The peptide is nudging a system that has drifted with age back toward its younger operating pattern, and once that nudge happens, the effect runs on its own for a while.

That is a different kind of pharmacology than something like a blood pressure medication that only works while it is in your system. The animal data backs up the pulse-then-rest model directly. In rat lifespan studies out of the Khavinson lab, Epithalon was given in a defined dosing window, not continuously, and produced a 13.5% increase in mean lifespan along with a meaningful drop in tumor incidence in a cancer-prone mouse strain. If a daily forever-protocol produced a better result, that would be the study someone ran. Nobody has, because the mechanism does not call for it.

The human circadian data points the same direction. A sublingual trial in 75 women ran 20 days of dosing and produced a 1.6 fold jump in urinary melatonin breakdown product, measured after the cycle ended, not during continuous administration. The effect showed up and persisted past the dosing window, which is the entire argument for cycling in the first place: you are not maintaining a drug level, you are triggering a reset.

The actual numbers: how long and how often

Here is where I will give you real numbers instead of hedging into uselessness. The doses and schedules here are for educational and informational purposes only. These peptides are sold for research use only and are not FDA-approved drugs. This is not medical advice. Consult a qualified physician before beginning any protocol.

Across the practitioner sources I track, cycle length converges tightly even where daily dose does not: 10 to 20 days per cycle, run two to three times a year, with months of rest in between. That is the piece of the Epithalon conversation almost nobody actually disagrees on. Where practitioners diverge is the per-day dose, split between a higher-dose camp (5 to 10 mg per day, tracing back to Epithalamin, the original bovine pineal extract used in the old Russian cohorts) and a lower-dose camp (500 mcg to 1 mg per day of the actual synthetic AEDG tetrapeptide sold today). That distinction matters if you are trying to match a modern vial to the old trial data, but it does not change the cycle-length answer. Whichever dose camp you land in, the window is the same 10 to 20 days.

Thymalin, the thymus-derived peptide the original poster ran alongside Epithalon, follows the identical cycle shape: a short course, typically 10 to 20 days, two to three times a year. That is not a coincidence. Thymalin comes from the same research program and the same underlying logic, that a short bioactive pulse triggers a change in gene expression that outlasts the dosing window. The mechanism target is different (thymic T-cell function rather than telomere and pineal biology), but the cycling rationale is shared.

What "longer cycle" actually buys you, and what it doesn't

I have had clients ask if running 30 or 40 days instead of 20 would just multiply the benefit. Nothing in the cited literature supports that. The rhesus monkey study on pineal restoration and the human circadian data both used defined windows in the 20 to 30 day range and got a real, measurable effect within that window. There is no dose-response curve published that says a longer cycle produces a proportionally bigger response, and the theoretical mechanism (a genomic reset, not a drug accumulating in tissue) does not predict one either.

What actually matters more than stretching the cycle is not skipping the rest period. The whole model depends on giving the body months to run on the restored signal before you pulse it again. If someone runs cycle after cycle back to back with no gap, they are not accelerating anything. They are just turning a pulsed protocol into an undocumented continuous one, and nobody has studied what that does.

I will also flag the piece that gets skipped in most of the enthusiastic Facebook posts: a 2019 Mendelian randomization study of 261,000 people found that people who are genetically born with longer telomeres have a lower rate of coronary heart disease but a higher rate of cancer, with no measurable benefit to grip strength, cognition, or frailty. That does not mean Epithalon is dangerous or that the telomere mechanism is fake. It means the simple "longer telomeres equals longer healthier life" story that gets repeated in these groups is not the full picture, and it is one more reason the cycled, rest-heavy protocol (rather than an aggressive daily push) is the sane way to run this compound.

If you are stacking Epithalon with other longevity peptides, I would point you to how I think about combination protocols in 5-Amino-1MQ for fatigue and energy, which walks through a similar logic of matching mechanism to schedule rather than just dosing more.

Read the full mechanism and dosing breakdown for each compound at the Epithalon and Thymalin pages before you plan a cycle. The community post that started this piece got the enthusiasm right. Now you have the numbers to go with it.